Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
O ChinotF Grisoli

Abstract

Most primary oligodendrogliomas and mixed gliomas (oligoastrocytoma) respond to treatment with procarbazine, lomustine, and vincristine (PCV), with response rates of approximately 80%. However, limited data on second-line treatments are available in patients with recurrent tumors. A novel second-generation alkylating agent, temozolomide, has recently demonstrated efficacy and safety in patients with recurrent glioblastoma multiforme and anaplastic astrocytoma. This study describes the effects of temozolomide in patients with recurrent anaplastic oligodendroglioma (AO) and anaplastic mixed oligoastrocytoma (AOA). Forty-eight patients with histologically confirmed AO or AOA who had received previous PCV chemotherapy were treated with temozolomide (150 to 200 mg/m2/d for 5 days per 28-day cycle). The primary end point was objective response. Secondary end points included progression-free survival (PFS), time to progression, overall survival (OS), safety, and tolerability. Eight patients (16.7%) experienced a complete response, 13 patients (27.1%) experienced a partial response (objective response rate, 43.8%), and 19 patients (39.6%) experienced stable disease. For the entire treatment group, median PFS was 6.7 months and median O...Continue Reading

References

Jul 1, 1992·Neurosurgery·J G CairncrossD A Ramsay
Mar 1, 1992·Journal of Neurosurgery·E G ShawD H Davis
Feb 1, 1992·British Journal of Cancer·E S NewlandsM H Brampton
Apr 1, 1988·Annals of Neurology·J G Cairncross, D R Macdonald
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G CairncrossC Schold
Apr 1, 1994·Neurosurgery·E G ShawD H Davis
Apr 30, 1993·International Journal of Radiation Oncology, Biology, Physics·L KleinbergM G Malkin
Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C ScholdD D Bigner
Mar 1, 1993·Neurosurgery·A P KyritsisV A Levin
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M O'ReillyP Lewis
Jan 1, 1996·Neurology·W P MasonL M DeAngelis
Oct 1, 1996·Journal of Neurosurgery·K PetersonJ G Cairncross
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E S NewlandsP G Richards
Jan 15, 1997·International Journal of Radiation Oncology, Biology, Physics·R R AllisonK H Shin
Aug 1, 1997·Journal of Neuro-oncology·C Daumas-DuportJ P Chodkiewicz
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·M BowerM H Brampton
Dec 13, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M C Chamberlain, P A Kormanik
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·M D PradosC B Wilson
Oct 17, 1998·Journal of the National Cancer Institute·J G CairncrossD N Louis
Nov 5, 1998·Neurosurgery·R SoffiettiD Schiffer
Apr 14, 1999·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Apr 14, 1999·CA: a Cancer Journal for Clinicians·D M ParkinJ Ferlay
Oct 26, 1999·Journal of Neuro-oncology·B JeremicJ Aleksandrovic
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K YungV A Levin
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins

❮ Previous
Next ❯

Citations

Apr 2, 2004·Nature Reviews. Cancer·Stanton L Gerson
Sep 17, 2004·Acta Oncologica·Hanna O MäenpääHeikki Minn
Jan 28, 2005·Journal of Neuro-oncology·Judith W M JeukenPieter Wesseling
May 4, 2005·Current Neurology and Neuroscience Reports·Roger StuppMonika E Hegi
Nov 11, 2005·Current Opinion in Neurology·Joachim M Baehring
Feb 16, 2006·The Oncologist·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 6, 2012·Current Treatment Options in Neurology·Nina A Paleologos, Ryan T Merrell
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory CairncrossMinesh Mehta
Feb 12, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Gregory CairncrossWalter J Curran
Apr 23, 2004·Current Neurology and Neuroscience Reports·Patrick Y Wen, Santosh Kesari
Jul 13, 2002·Expert Review of Anticancer Therapy·A A BrandesL M Pasetto
Apr 15, 2003·Current Neurology and Neuroscience Reports·Marc SansonKhe Hoang-Xuan
Nov 9, 2005·Expert Review of Neurotherapeutics·Adam M Sonabend, Maciej S Lesniak
Oct 16, 2004·Expert Review of Anticancer Therapy·Maciej M MrugalaPatrick Y Wen
Oct 31, 2003·Current Treatment Options in Oncology·Thomas L EllisRebekah C Austin
Jul 21, 2005·Journal of Neurosurgery·Mark E ShaffreyM Beatriz S Lopes
Jun 27, 2008·Current Treatment Options in Neurology·Jaishri Blakeley, Stuart Grossman
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Intergroup Radiation Therapy Oncology Group Trial 9402Walter Curran
Oct 13, 2006·Current Treatment Options in Oncology·Lyndon Kim, Michael Glantz
Sep 3, 2010·Acta neurochirurgica·Michael D JenkinsonBrian Haylock
Dec 9, 2008·The Cancer Journal·Gregory Cairncross, Robert Jenkins
Jun 12, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Chao ChenShenhong Wu
Aug 3, 2013·Current Treatment Options in Oncology·Patrick RothMichael Weller
Jan 25, 2005·Journal of Neuro-oncology·Thomas N Byrne
Jun 22, 2005·Current Treatment Options in Neurology·Warren P Mason
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Hoang-XuanJ Y Delattre
Mar 29, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C LebrunM Frenay
Nov 5, 2005·Cancer·Enrico FranceschiLauren E Abrey
May 19, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jorge Molina SaeraGaspar Reynés Muntaner
Jun 9, 2006·Expert Review of Anticancer Therapy·Jennifer I Stern, Jeffrey J Raizer
Aug 24, 2006·Expert Review of Anticancer Therapy·Nicole Mutter, Roger Stupp
Jun 26, 2007·Pediatric Blood & Cancer·Seong L KhawDavid M Ashley
Jan 25, 2013·Current Treatment Options in Neurology·Mairéad G McNamaraWarren P Mason
Sep 16, 2010·Current Treatment Options in Neurology·Eudocia C QuantAndrew D Norden
Feb 15, 2014·Journal of Korean Neurosurgical Society·Ho-Shin GwakSeung Hoon Lee
Jul 6, 2014·Journal of Neuro-oncology·Manmeet S Ahluwalia, Susan M Chang
May 6, 2015·Expert Review of Neurotherapeutics·Emilie Le RhunMarc C Chamberlain
Feb 6, 2004·American Journal of Clinical Oncology·Michael L Gruber, Ward P Buster
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Mar 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kurt A JaeckleJan C Buckner
Jun 15, 2007·Journal of Neuro-oncology·Marie Pierre SunyachDidier Frappaz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.